Patto came into a management role when AHZ bleeding cash....then produces (with the help of some rebates) a quarter with positive cash flow as predicted. He delivered so should be given a far go. And if he delivers on his next 12 month forecast the SP will not be sub $1.
Harsh to attribute to patto trial results that were in motion before he had executive role. And despite the results I bet he gets $ for some form of partnership deal to pay for next round of trials. I remember watching a video of Ian Frazer about developing his world famous vaccine. The first set of results were not as positive as expected so he did a tweek and presto the vaccination worked.
Patto has done a very good job so far IMO
Ann: Response to Aware Query, page-81
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$9.91 |
Change
-0.090(0.90%) |
Mkt cap ! $209.4M | |||
| Open | High | Low | Value | Volume |
| $10.00 | $10.00 | $9.65 | $70.76K | 7.202K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 300 | $9.80 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $9.91 | 475 | 2 |
View Market Depth
| Last trade - 16.10pm 12/11/2024 (20 minute delay) ? |
| AVR (ASX) Chart |